HighTower Advisors’s Clover Health Investments CLOV Stock Holding History

HighTower Advisors’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,091	Closed	-$9.74K	–	3800
2024 Q4	$9.74K	Sell	3,091 -31,272	-91%	-$112K	﹤0.01%	3585
2024 Q3	$97K	Buy	+34,363	New	+$78.7K	﹤0.01%	3321
2022 Q3	–	Sell	-12,966	Closed	-$27K	–	3185
2022 Q2	$27K	Buy	12,966 +752	+6%	+$2K	﹤0.01%	2971
2022 Q1	$45K	Buy	12,214 +1,144	+10%	+$3.32K	﹤0.01%	3083
2021 Q4	$41K	Buy	11,070 +139	+1%	+$853	﹤0.01%	3043
2021 Q3	$80K	Buy	10,931 +511	+5%	+$4.37K	﹤0.01%	2876
2021 Q2	$140K	Sell	10,420 -6,774	-39%	-$66.5K	﹤0.01%	2739
2021 Q1	$133K	Buy	+17,194	New	+$194K	﹤0.01%	2705

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

HighTower Advisors's CLOV Position: Q1 2025 in Review

HighTower Advisors sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 3,091 shares — an estimated $9.74K sold.

HighTower Advisors first reported a position in CLOV in Q1 2021 and held it in 8 quarters. The position peaked at $140K in Q2 2021. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

HighTower Advisors reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
HighTower Advisors sold 3,091 Clover Health Investments shares in Q1 2025, an estimated $9.74K.
HighTower Advisors first reported a position in Clover Health Investments in Q1 2021 and held it in 8 quarters.
HighTower Advisors's Clover Health Investments position peaked at $140K in Q2 2021.
202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.